DSIP is not approved by the FDA or any major global regulatory body for human therapeutic use
Back to Journals Journal of Hepatocellular Carcinoma Volume 8 Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial Authors Wang LZ, Hu XX, Shen XC , Wang TC , Zhou S Received 5 August 2021 Accepted for publication 23 September 2021 Published 5 October 2021 Volume 2021:8 Pages 12211232 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 5 Editor who approved publication: Dr Ahmed Kaseb Li-Zhou Wang, 1, * Xiao-Xia Hu, 2, * Xiang-Chun Shen, 2, 3 Tian-Cheng Wang, 4 Shi Zhou 1 1 Department of Interventional Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China
Importantly, the GLP-1R-cholesterol binding sites identified here do not overlap with previously predicted cholesterol consensus motifs (CCM) (22) or Cholesterol Recognition Amino Acid Consensus (CRAC) motifs (52) identified for other GPCRs, confirming the theory that GPCRs lack predictable primary sequence consensus motifs for cholesterol binding (53, 54)
Molecular Biology Reports 41, 49194927
